RxDoctor Payments Data

Jose Pagan, MD

Vascular Surgery · Manati, PRNPI 1508877234

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Johnson & Johnson at 23.2% of the total. Reporting peaked in 2019 at $311 and has fallen 93.1% since, to $21 in 2025. That places this record below the midpoint for vascular surgery clinicians in PR, where the typical reported total is $4,475.

$716in general payments, 2019–2025

Across 26 payments — averaging $27.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$166
  • Bard Peripheral Vascular, Inc.$161
  • Medtronic$153
  • Davol Inc.$134
  • PBG Puerto Rico LLC$65
  • BD$19
  • plus $17 from 1 others

What the payments were for

  • Food & beverage$716100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson8$166
Bard Peripheral Vascular, Inc.3$161
Medtronic(2 entities)9$153
Davol Inc.1$134
PBG Puerto Rico LLC3$65
BD1$19
Chiesi USA, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$716 in reported general payments places this provider in the 20th percentile of 20 vascular surgery providers in Puerto Rico.

See all vascular surgery providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$9,341
Medicare patients
24
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cilostazol21$485
Atorvastatin Calcium12$115

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Manati

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →